Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 replaces the previous Revision: v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a new Revision: v3.4.2 banner and removed the previous government-funding/operating-status notice associated with Revision: v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a global notice about government funding lapse and NIH Clinical Center operating status with links to cc.nih.gov and opm.gov. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary display option and a QC-status indicator; updated the page revision to v3.4.0 and adjusted capitalization of No FEAR Act terms.SummaryDifference0.2%

- Check75 days agoChange DetectedA large number of core terms and sections central to the study record have been deleted, including disease names, treatments, eligibility criteria, location details, and investigators. This reduces the page's clarity and navigability.SummaryDifference17%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.